Tech.eu
·
1 day ago
Monumental, a construction robotics company, raised $32 million in Series B funding to expand its fleet of autonomous bricklaying robots powered by its AI platform Atrium. The company operates over 150 robots across the Netherlands and UK that have helped construct more than 100 homes, with nearly half completed in the past three months. The funding will support expansion of its engineering team, increased robot deployment across Europe, and preparation for US market entry.
TechCrunch AI
·
1 day ago
Rime, a voice AI startup founded in 2022, raised $24 million in Series A funding led by M13 Ventures to develop conversational AI systems for enterprise customer service calls. The company operates a recording studio in San Francisco to train models on proprietary conversational data and now focuses on speech-to-speech models with latency reductions rather than orchestrating multiple separate models. Rime plans to expand its 35-person team and aims to capture enterprise contracts from companies that currently rely on legacy interactive voice response systems.
Wired AI
·
1 day ago
Hemispheric, founded by an Apple FaceID co-inventor, raised $52 million to develop AI models that diagnose cognitive disorders by analyzing brain electrical activity from EEG headsets. The startup trained its deep-learning model on 250,000 hours of brain data collected from 100,000 people and plans to submit its first product for PTSD diagnosis to the FDA in early 2025, with public availability targeted for late 2027. The approach aims to replace subjective questionnaires with objective AI-assisted diagnosis that could eventually function as simply and cheaply as a blood test.
TechCrunch AI
·
1 day ago
Emergent, an Indian AI coding startup, raised $130 million in Series C funding at a $1.5 billion valuation, achieving unicorn status five months after its previous $70 million raise. The company reported $120 million in annual run-rate revenue with over 200,000 paying customers, up 70% in the last four months. Emergent plans to accelerate product development, expand its San Francisco office by 30 to 40 employees, and open a European office to support growth across non-technical users building business applications.
The Neuron
·
1 day ago
OpenAI's path to going public is encountering obstacles from multiple lawsuits, strained relations with Microsoft, and competitive pressure from Anthropic's growing valuation. The company's valuation has been set at $80 billion in recent funding rounds, while Anthropic has reached $60 billion, narrowing the gap between the two AI labs. These combined pressures may force OpenAI to reconsider its timeline for an IPO or the terms on which it eventually goes public.
Tech.eu
·
1 day ago
Float, a revenue-based financing platform for European tech companies, raised €4.5 million in Series A funding led by CHAPTERS Group AG. The company has distributed over €100 million to 130 tech businesses since 2022 and plans to evolve into an AI-native financial platform combining lending with AI-powered financial management tools. The funding will enable Float to double its team, expand in the UK market, and add automated financial insights and expense management features to its core lending business.
Sifted
·
1 day ago
Neko Health, a preventative healthtech company founded by Hjalmar Nilsonne and Spotify's Daniel Ek, uses unflattering avatars of users' bodies alongside health scan results to motivate behavioral changes. The company raised $700 million in Series C funding and reports 80% yearly customer retention, with retention improving from the second to third scan as users engage with the platform's new features including AI-powered body composition analysis. Following avatar visualization, users reportedly adopt lifestyle changes such as improved diet and exercise habits, with the company expanding to New York after opening a second Stockholm clinic.
TechCrunch AI
·
1 day ago
Miles Wang, an OpenAI researcher specializing in AI for scientific discovery, is leaving to start a drug discovery startup with several other OpenAI researchers. The new company is in funding discussions with Lightspeed to raise $200 million at a $2 billion valuation. The startup would focus on developing AI models to identify new uses for existing drugs, potentially reducing time to market compared to discovering entirely new treatments.
